Skip to main content

Illumina shares spike after firm unveils new gene-sequencing product, upbeat quarterly forecast

Illumina surged 15 percent on Tuesday, a day after the firm unveiled a new gene-sequencing product and gave a strong fourth-quarter sales forecast.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.